AlphaYouJC
Insider selling
Jon Congleton sold $2M of Mineralys Therapeutics, Inc. (MLYS) stock
Jon Congleton, Chief Executive Officer of Mineralys Therapeutics, Inc. (MLYS), sold 75,000 shares of MLYS stock worth $2M, per an SEC Form 4 filed Jun 30, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Jun 30, 2026.
MLYS has moved +4.9% since the trade date, from $26.98 to $28.31 (Sep 21, 2026 close).
- Traded
- Jun 30, 2026
- Disclosed
- Jun 30, 2026
- Filing delay
- 0 days
- Price since
- +4.9%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More MLYS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.